España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Genfit
GNFT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$4.37
-0.13
-2.89%
At close: -
$4.35
-0.02
-0.46%
After Hours: 4:45 AM EDT
Get Report
Comment
Genfit (GNFT) Forecast
News
Earnings
Genfit (GNFT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Genfit (NASDAQ:GNFT) Stock
Genfit Stock (NASDAQ: GNFT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, October 14, 2024
Baidu, XPeng And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
Friday, October 11, 2024
HC Wainwright & Co. Reiterates Buy on Genfit,...
Benzinga Newsdesk
Tuesday, September 24, 2024
Top 4 Health Care Stocks That May Keep You Up At Night
Avi Kapoor
Friday, September 20, 2024
HC Wainwright & Co. Reiterates Buy on Genfit,...
Benzinga Newsdesk
Market-Moving News for September 20th
Benzinga Newsdesk
GENFIT shares are trading higher. The company...
Benzinga Newsdesk
Why Nike Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, September 19, 2024
CORRECTION: Genfit H1 2024 Adj. EPS €0.53; Re...
Benzinga Newsdesk
Monday, July 29, 2024
HC Wainwright & Co. Reiterates Buy on Genfit,...
Benzinga Newsdesk
Tuesday, June 11, 2024
FDA Fast-Tracks Ipsen And Genfit's New Liver Disease Treatment, Iqirvo
Shivani Kumaresan
HC Wainwright & Co. Maintains Buy on Genfit, ...
Benzinga Newsdesk
Monday, June 10, 2024
Trading Halt: Halt status updated at 5:50:00 ...
Benzinga Newsdesk
GENFIT Says Iqirvo Is First-ever Drug Develop...
Benzinga Newsdesk
Ipsen Says Iqirvo Secured FDA Accelerated App...
Benzinga Newsdesk
Trading Halt: Halted at 4:42:03 p.m. ET - Tra...
Benzinga Newsdesk
Thursday, June 06, 2024
HC Wainwright & Co. Reiterates Buy on Genfit,...
Benzinga Newsdesk
Friday, May 31, 2024
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Why Zscaler Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on Genfit,...
Benzinga Newsdesk
Friday, April 05, 2024
HC Wainwright & Co. Reiterates Buy on Genfit,...
Benzinga Newsdesk
Thursday, April 04, 2024
Genfit FY23 EPS $(0.62) Down From $(0.49) YoY...
Benzinga Newsdesk
GENFIT FY23 EPS €(0.58) Vs €(0.48) YoY; Reven...
Benzinga Newsdesk
Earnings Scheduled For April 4, 2024
Benzinga Insights
Thursday, February 29, 2024
GENFIT 2023 Revenues €28.6M, Up From €20.2M Y...
Benzinga Newsdesk
Friday, December 08, 2023
HC Wainwright & Co. Reiterates Buy on Genfit,...
Benzinga Newsdesk
Thursday, December 07, 2023
Ipsen Confirms FDA Grants Priority Review For New Drug Application For Elafibranor For The Treatment Of Rare Cholestatic Liver Disease, PBC
Charles Gross
Wednesday, December 06, 2023
GENFIT Announces Publication In The Journal O...
Benzinga Newsdesk
Tuesday, November 14, 2023
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Tuesday, September 26, 2023
GENFIT Announces Publication In Nature Medici...
Benzinga Newsdesk
Thursday, September 21, 2023
HC Wainwright & Co. Reiterates Buy on Genfit,...
Benzinga Newsdesk
Wednesday, September 20, 2023
Genfit H1 EPS $(0.4578) Down From $(0.23) YoY, Sales $16.76M Up From $9.62M YoY
Happy Mohamed
Thursday, July 13, 2023
Intercept Pharma Gets Double Upgrade: Analyst Says OCA Combo Therapy Can Extend PBC Business
Vandana Singh
Monday, July 03, 2023
Analyst Expectations for Genfit's Future
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Genfit, ...
Benzinga Newsdesk
Friday, June 30, 2023
Genfit's Miss Is CymaBay Therapeutics' Gain: Analyst Says Rival Data Leaves Room for Seladelpar To Emerge As Best-In-Class
Vandana Singh
Ipsen, Genfit's Elafibranor Shows Promise In Primary Biliary Cholangitis Patients
Vandana Singh
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Why Renalytix Are Trading Higher By Over 48%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Genfit shares are trading higher after the co...
Benzinga Newsdesk
Ipsen And Genfit Announced Topline Data From ...
Benzinga Newsdesk
Thursday, June 22, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Thursday, June 01, 2023
HC Wainwright & Co. Reiterates Buy on Genfit,...
Benzinga Newsdesk
Wednesday, May 24, 2023
HC Wainwright & Co. Reiterates Buy on Genfit,...
Benzinga Newsdesk
Monday, May 22, 2023
What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's 'OCA In NASH May Never Occur
Vandana Singh
Monday, April 17, 2023
HC Wainwright & Co. Maintains Buy on Genfit, ...
Benzinga Newsdesk
Thursday, April 13, 2023
Genfit FY EPS $(0.53) Down From $1.46 YoY
Michael Horton
Earnings Scheduled For April 13, 2023
Benzinga Insights
Monday, October 10, 2022
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Wednesday, September 28, 2022
GENFIT Reports H1 2022 Revenues And Other Inc...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch